Vitiligo – Adolescents and Adults

Individuals who have a diagnosis of non-segmental vitiligo may qualify for this clinical research trial and receive investigational oral medication or placebo. 

• Age: ≥ 12 years old 
• Fitzpatrick skin type V-VI for adolescent only
• Vitiligo for ≥3 months 
• BSA 4% - 60% and facial BSA ≥ 0.5% 
• Fitzpatrick skin type V-VI for adults
• No prior exposure to JAKi or surgical treatment for vitiligo 

Patients will be asked to visit the clinic about 11 times over approximately 60 weeks. There is no cost to participate, and participants will be reimbursed for their time and travel. 

For further information on the study, please follow the link: 

Trial ID: NCT05583526

If you are interested in participating in a vitiligo clinical trial, please submit your details and our team will be in touch: expression of interest form